Venture Capital News | Private Equity News
Summary
Monogram Health Closes $375M Growth Capital Raise to Support Continued Expansion of Innovative In-Home Kidney and Polychronic Care ModelMilestone funding from leading strategic and financial investors will help accelerate companys mission to measurably improve outcomes for patients living with polychronic conditions, including chronic kidney and end-stage renal diseaseNASHVILLE, Tenn., January 9, 2023-- Monogram Health, a value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease, today announced it has closed on $375 million of new funding. Monogram has made bold strides in offering patients and families enhanced access to much needed health services, while substantially improving the overall affordability of their care. This latest milestone growth funding round with substantive new and existing partners is driven by our disciplined commitment to, and demonstration of, outstanding clinical results. Im proud to work alongside Monograms focused leadership team to continue to propel the company as the sustainable clinical leader for patients across the United States." BofA Securities acted as sole placement agent and Cravath, Swaine & Moore LLP served as legal counsel to Monogram in connection with the transaction.